TrialNature medicine2025

Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study.

Moti N Ramgopal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.